Coagulogram of blood

A blood coagulation panel is a group of tests that evaluates parts of the clotting system. It commonly includes prothrombin time or PT, INR, APTT or PTT, fibrinogen and sometimes thrombin time, D-dimer or additional tests depending on the laboratory and clinical question.

Clotting is not simply thick or thin blood. It is a cascade involving clotting factors, platelets, vessel walls, liver function, vitamin K, inflammation and medications. A coagulation panel should therefore not be read as one general score. Each marker reflects a different part of the system.

PT and INR

Prothrombin time evaluates the extrinsic and common pathways of coagulation. INR is a standardized way to report PT and is especially important for warfarin monitoring. Prolonged PT/INR may be related to warfarin, vitamin K deficiency, impaired liver function, clotting-factor deficiency or severe systemic illness.

For a person taking warfarin, the target INR depends on the reason for therapy: atrial fibrillation, a mechanical valve, thrombosis and other situations require different ranges. Changing the dose based on one result without medical guidance is dangerous because too high an INR increases bleeding risk and too low an INR may not protect from thrombosis.

APTT and the intrinsic pathway

APTT evaluates another part of the coagulation cascade, including intrinsic and common pathway factors. It matters when hemophilia, certain factor deficiencies, heparin effect, antiphospholipid antibodies or specific clotting disorders are considered. A prolonged APTT does not always mean bleeding tendency; lupus anticoagulant can paradoxically be associated with thrombosis.

When APTT is abnormal, clinicians may order mixing studies, clotting-factor assays, antiphospholipid antibody testing or heparin-related tests. Without that, it is impossible to know whether the issue is factor deficiency, an inhibitor, medication or a laboratory feature.

Fibrinogen, platelets and D-dimer

Fibrinogen is the protein used to form the fibrin mesh of a clot. It may rise with inflammation, infection, pregnancy, trauma and cardiovascular risk, and fall with severe liver disease, DIC, massive bleeding or rare deficiencies. It is therefore linked to both inflammation and clotting.

Platelets are usually assessed in a complete blood count, but the clotting picture is incomplete without them. D-dimer reflects fibrin breakdown and may rise with thrombosis, inflammation, infection, pregnancy, surgery and many other states. It is useful in specific diagnostic algorithms, but by itself it does not prove thrombosis.

What affects the result

Warfarin, heparin, direct oral anticoagulants, aspirin, antiplatelet drugs, liver disease, vitamin K deficiency, antibiotics, alcohol, pregnancy, inflammation, cancer and acute infections can affect the panel. Sampling technique also matters: underfilled tubes, delayed processing and contamination can distort results.

All medications, supplements and bleeding history should be reported before testing. Fish oil, high-dose vitamin E, some herbs and supplements may affect bleeding tendency or interact with medications, even when standard coagulation markers do not change clearly.

Nutrition, keto and vitamin K

During LCHF, intake of green vegetables, eggs, meat, fish and fats may change. For most people this is not a clotting problem. But in people taking warfarin, sudden changes in vitamin K from greens can change INR. The goal is not to avoid greens completely, but to keep intake stable and coordinate monitoring with a clinician.

Keto is not a reason to stop anticoagulants, change doses or ignore bleeding. Black stool, blood in urine, unusual bruising, nosebleeds, severe headache, chest pain, shortness of breath or one-sided leg swelling are medical issues, not macronutrient-adjustment questions.

Limits of the panel

A normal coagulation panel does not exclude all causes of thrombosis or bleeding. It can be normal in hereditary thrombophilias, platelet-function disorders, vascular causes of bleeding or a localized clot. The test must be read with symptoms, history, medications, procedures, pregnancy, cancer risk and family history.